Dr Frank King has kidney cancer and has been prescribed the drugs Pazopanib, Sunitinib and is currently on a clinical trial through Bristol-Myers Squibb for Nivolumab. Here, along with his oncologist, Dr Kate Fife of Addenbrooke’s Hospital, Cambridge, Frank talks about those drugs effects and his kidney cancer journey.
Pazopanib, Sunitinib, Nivolumab: A Patient Consultant Experience
.
Malcolm Packer
Malcolm is Chief Executive Officer at Kidney Cancer UK and Kidney Cancer Scotland and has worked with the charity in various capacities for over 15 years.
Donate
With your help we can beat kidney cancer together
